ACADIA 制药 ACAD
$21.23 −$0.01 (-0.05%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $21.23 0.00%
开盘$21.00
昨收$21.24
当日区间$20.59 – $21.45
成交量1.77M
市值$3.67B
市盈率（TTM）10.0
股息率–
ACAD 相关新闻
匹配 ACADIA Pharmaceuticals 或代码 ACAD 的头条新闻，按最新排序。
- CCORF Maintains ACADIA Pharmaceuticals(ACAD.US) With Buy Rating, Maintains Target Price $36
- A Quick Look at Today's Ratings for ACADIA Pharmaceuticals(ACAD.US), With a Forecast Between $31 to $36
- Analysts Are Bullish on These Healthcare Stocks: ACADIA Pharmaceuticals (ACAD), Kyverna Therapeutics, Inc. (KYTX) 正面
- Analysts' Top Healthcare Picks: Kyverna Therapeutics, Inc. (KYTX), ACADIA Pharmaceuticals (ACAD)
- Morgan Stanley Maintains ACADIA Pharmaceuticals(ACAD.US) With Hold Rating, Maintains Target Price $26
- BofA Securities Maintains ACADIA Pharmaceuticals(ACAD.US) With Buy Rating, Raises Target Price to $31 正面
- A Quick Look at Today's Ratings for ACADIA Pharmaceuticals(ACAD.US), With a Forecast Between $36 to $38
- RBC Capital Maintains ACADIA Pharmaceuticals(ACAD.US) With Buy Rating, Raises Target Price to $37 正面
- Deutsche Bank Maintains ACADIA Pharmaceuticals(ACAD.US) With Buy Rating, Raises Target Price to $38 正面
- A Quick Look at Today's Ratings for ACADIA Pharmaceuticals(ACAD.US), With a Forecast Between $36 to $40
- BMO Capital Initiates ACADIA Pharmaceuticals(ACAD.US) With Buy Rating, Announces Target Price $36
- UBS Maintains ACADIA Pharmaceuticals(ACAD.US) With Buy Rating, Maintains Target Price $49
- UBS Maintains ACADIA Pharmaceuticals(ACAD.US) With Buy Rating, Raises Target Price to $49 正面
- Needham Maintains ACADIA Pharmaceuticals(ACAD.US) With Buy Rating, Raises Target Price to $41 正面
- Citi Maintains ACADIA Pharmaceuticals(ACAD.US) With Buy Rating, Raises Target Price to $39 正面
暂无评论——快来第一个聊聊 ACAD。
登录后参与讨论。